Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Lutgehetmann

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Seminars in Liver Disease|May 5, 2006
Small animal model systems for studying hepatitis B virus replication and pathogenesisMaura Dandri, Marc Lutgehetmann, Tassilo Volz, et al.
Antiviral Therapy|September 13, 2006
Temporary HBV resolution in an HIV-coinfected patient during HBV-directed combination therapy followed by relapse of HBVKarsten Wursthorn, Peter Buggisch, Marc Lutgehetmann, et al.
Antiviral Therapy|April 9, 2008
Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replicationMarc Lutgehetmann, Tassilo Volzt, Alexander Quaas, et al.
Hepatology (Baltimore, Md.)|August 13, 2008
Virion half-life in chronic hepatitis B infection is strongly correlated with levels of viremiaMaura Dandri, John M Murray, Marc Lutgehetmann, et al.
Gastroenterology|September 15, 2007
Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patientsTassilo Volz, Marc Lutgehetmann, Paul Wachtler, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 1, 2011
Primary human hepatocytes on biodegradable poly(l-lactic acid) matrices: a promising model for improving transplantation efficiency with tissue engineeringEva Török, Marc Lutgehetmann, Jeanette Bierwolf, et al.
Tissue Engineering. Part A|May 23, 2012
Primary human hepatocytes from metabolic-disordered children recreate highly differentiated liver-tissue-like spheroids on alginate scaffoldsJeanette Bierwolf, Marc Lutgehetmann, Steffen Deichmann, et al.
Hepatology (Baltimore, Md.)|June 26, 2010
In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in miceMarc Lutgehetmann, Tassilo Volz, Anne Köpke, et al.
Biotechnology and Bioengineering|September 9, 2010
Primary rat hepatocyte culture on 3D nanofibrous polymer scaffolds for toxicology and pharmaceutical researchJeanette Bierwolf, Marc Lutgehetmann, Kai Feng, et al.
Hepatology (Baltimore, Md.)|August 31, 2006
Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis BKarsten Wursthorn, Marc Lutgehetmann, Maura Dandri, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Seminars in Liver Disease|May 5, 2006
Small animal model systems for studying hepatitis B virus replication and pathogenesisMaura Dandri, Marc Lutgehetmann, Tassilo Volz, et al.
Antiviral Therapy|September 13, 2006
Temporary HBV resolution in an HIV-coinfected patient during HBV-directed combination therapy followed by relapse of HBVKarsten Wursthorn, Peter Buggisch, Marc Lutgehetmann, et al.
Antiviral Therapy|April 9, 2008
Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replicationMarc Lutgehetmann, Tassilo Volzt, Alexander Quaas, et al.
Hepatology (Baltimore, Md.)|August 13, 2008
Virion half-life in chronic hepatitis B infection is strongly correlated with levels of viremiaMaura Dandri, John M Murray, Marc Lutgehetmann, et al.
Gastroenterology|September 15, 2007
Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patientsTassilo Volz, Marc Lutgehetmann, Paul Wachtler, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 1, 2011
Primary human hepatocytes on biodegradable poly(l-lactic acid) matrices: a promising model for improving transplantation efficiency with tissue engineeringEva Török, Marc Lutgehetmann, Jeanette Bierwolf, et al.
Tissue Engineering. Part A|May 23, 2012
Primary human hepatocytes from metabolic-disordered children recreate highly differentiated liver-tissue-like spheroids on alginate scaffoldsJeanette Bierwolf, Marc Lutgehetmann, Steffen Deichmann, et al.
Hepatology (Baltimore, Md.)|June 26, 2010
In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in miceMarc Lutgehetmann, Tassilo Volz, Anne Köpke, et al.
Biotechnology and Bioengineering|September 9, 2010
Primary rat hepatocyte culture on 3D nanofibrous polymer scaffolds for toxicology and pharmaceutical researchJeanette Bierwolf, Marc Lutgehetmann, Kai Feng, et al.
Hepatology (Baltimore, Md.)|August 31, 2006
Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis BKarsten Wursthorn, Marc Lutgehetmann, Maura Dandri, et al.
Pageof 2